ENMD-2076 L-()-Tartaric acid
99%
- Product Code: 100418
CAS:
1291074-87-7
| Molecular Weight: | 525.5599999999999 g./mol | Molecular Formula: | C₂₅H₃₁N₇O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
ENMD-2076 L-()-Tartaric acid is primarily utilized in the pharmaceutical industry as an active ingredient in the development of targeted cancer therapies. It functions as a multi-kinase inhibitor, specifically targeting Aurora A, VEGFR, and FLT3 kinases, which play critical roles in tumor growth and angiogenesis. This makes it a promising candidate for treating various cancers, including breast cancer, ovarian cancer, and acute myeloid leukemia. Additionally, its tartaric acid component aids in improving the solubility and stability of the compound, enhancing its bioavailability and efficacy in therapeutic applications. Research and clinical trials continue to explore its potential in combination therapies and its effectiveness in overcoming drug resistance in cancer treatment.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Light Brown To Khaki Solid |
| Purity (%) | 98.5-100 |
| Lcms | Consistent With Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿3,840.00 |
+
-
|
| 0.025 | 10-20 days | ฿11,520.00 |
+
-
|
ENMD-2076 L-()-Tartaric acid
ENMD-2076 L-()-Tartaric acid is primarily utilized in the pharmaceutical industry as an active ingredient in the development of targeted cancer therapies. It functions as a multi-kinase inhibitor, specifically targeting Aurora A, VEGFR, and FLT3 kinases, which play critical roles in tumor growth and angiogenesis. This makes it a promising candidate for treating various cancers, including breast cancer, ovarian cancer, and acute myeloid leukemia. Additionally, its tartaric acid component aids in improving the solubility and stability of the compound, enhancing its bioavailability and efficacy in therapeutic applications. Research and clinical trials continue to explore its potential in combination therapies and its effectiveness in overcoming drug resistance in cancer treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :